日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Refining O-RADS MRI: beyond malignancy risk

改进 O-RADS MRI:超越恶性肿瘤风险

Harth, Sebastian; Meinhold-Heerlein, Ivo

SNAP-Tag-Based Antibody-Drug Conjugates Targeting Epidermal Growth Factor Receptor 1, Epidermal Growth Factor Receptor 2, Trophoblast Cell-Surface Antigen 2, and Tissue Factor for Ovarian Cancer Treatment

基于SNAP标签的抗体-药物偶联物靶向表皮生长因子受体1、表皮生长因子受体2、滋养层细胞表面抗原2和组织因子,用于卵巢癌治疗

Zhang, Chaoyu; Sheng, Wenjie; Mohiuddin, T M; Al-Rawe, Marwah; Schmitz, Roland; Niebert, Marcus; Zeppernick, Felix; Meinhold-Heerlein, Ivo; Hussain, Ahmad Fawzi

Synthetic zipper mediated pre-targeting system for near-infrared photoimmunotherapy

用于近红外光免疫疗法的合成拉链介导的预靶向系统

Mohiuddin, T M; Zhang, Chaoyu; Sheng, Wenjie; Al-Rawe, Marwah; El-Merhie, Natalia; Zeppernick, Felix; Meinhold-Heerlein, Ivo; Hussain, Ahmad Fawzi

The Paradox of Endometriosis in Mayer-Rokitansky-Kuster-Hauser Syndrome: Applying Three Criteria to Discriminate Between Retrograde Menstruation/Implantation and Coelomic Metaplasia/Embryonic Cell Rests Theories

Mayer-Rokitansky-Kuster-Hauser综合征中子宫内膜异位症的悖论:应用三个标准区分逆行性月经/着床和体腔化生/胚胎细胞残余理论

Konrad, Lutz; Riaz, Muhammad Assad; Zeppernick, Felix; Zeppernick, Magdalena; Meinhold-Heerlein, Ivo; Salmeri, Noemi; Viganò, Paola; Somigliana, Edgardo; Vercellini, Paolo

Multiplex Immunofluorescence Reveals Therapeutic Targets EGFR, EpCAM, Tissue Factor, and TROP2 in Triple-Negative Breast Cancer.

多重免疫荧光揭示了三阴性乳腺癌的治疗靶点 EGFR、EpCAM、组织因子和 TROP2

Mohiuddin T M, Sheng Wenjie, Zhang Chaoyu, Al-Rawe Marwah, Tchaikovski Svetlana, Zeppernick Felix, Meinhold-Heerlein Ivo, Hussain Ahmad Fawzi

The Contribution of CD26-Negative Fibroblasts to Endometrial Scarring

CD26阴性成纤维细胞对子宫内膜瘢痕形成的作用

Riaz, Muhammad Assad; Pecher, Clara Marie; Kary, Franziska Louisa; Maoga, Jane Bosibori; Dietze, Raimund; Zeppernick, Felix; Meinhold-Heerlein, Ivo; Konrad, Lutz

Non-Invasive Diagnosis of Endometriosis by Questionnaires in Patients Using Contraception

通过问卷调查对使用避孕措施的患者进行子宫内膜异位症的非侵入性诊断

Zeppernick, Felix; Balimuttajjo, Samira; Schorr, Christian; Sibelius, Florian; Schuler, Manuela; Harth, Sebastian; Seeger, Sarah; Löffelmann, Anna; Riaz, Muhammad A; Meinhold-Heerlein, Ivo; Konrad, Lutz

Intergroup statement: opportunistic salpingectomy-molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North-Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss)

跨组声明:机会性输卵管切除术——分子病理学、临床结果及对实践的影响(德国卵巢癌委员会、德国东北部妇科肿瘤学会 (NOGGO)、奥地利妇科肿瘤学会 (AGO Austria) 和瑞士妇科肿瘤学会 (AGO Swiss))

Pölcher, Martin; Wimberger, Pauline; Meinhold-Heerlein, Ivo; Runnebaum, Ingo; Schüler-Toprak, Susanne; Mahner, Sven; Grimm, Christoph; Heinzelmann-Schwarz, Viola; Hasenburg, Annette; Sehouli, Jalid

FIGO best practice guidance for diagnosis and treatment of fibroids

FIGO关于子宫肌瘤诊断和治疗的最佳实践指南

Meinhold-Heerlein, Ivo; Purandare, Nikhil; Murji, Ally; Fogarty, Paul; Beyeza, Jolly; Descamps, Philippe

FIGO-GCH joint consensus statement on the current status and recommendations for the use of blind intrauterine procedures in the evaluation and management of women with suspected intrauterine pathologies

FIGO-GCH关于盲法宫内检查在评估和管理疑似宫内病变妇女中的应用现状及建议的联合共识声明

Villegas-Echeverri, Juan Diego; Pope, Rachel; Robert, Magali; Meinhold-Heerlein, Ivo; Haimovich, Sergio; Carugno, José; Pacheco, Luis A; Sardo, Attilio Di Spiezio